Skip to main content

UBS Group AG

Position in CRVO — CervoMed Inc.

CIK 1610520 ZURICH, V8

Position in CRVO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,075
-$17,566 QoQ
Shares Held
992
-81.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 37 holders
Holding Since
Jun 2022
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRVO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. CRVO ranks #487 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRVO

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,075 992
2026-03-31 $20,641 5,239
2025-12-31 $8,238 1,043
2025-09-30 $27,311 3,376
2025-06-30 $35,179 5,593
2025-03-31 $62,100 6,787
2024-12-31 $101,473 43,365
2024-09-30 $37,040 2,537
2024-06-30 $27,974 1,634
2023-06-30 DFFN 60
2023-03-31 DFFN 470
2022-12-31 DFFN 323
2022-09-30 DFFN 856
2022-06-30 DFFN 430